CLINICAL STUDY ON THE EFFICACY AND CONTINUOUS DOCETAXEL BASED CHEMOTHERAPY TREATMENT FOR CASTRATION-RESISTANT PROSTATE CANCER

CHIKAZAWA IPPEI; INOUE SHIN'YA; NAKAZAWA YUSUKE; NAKAI DAN; MORITA NOBUYO; TANAKA TATSURO; MOTOO YOSHIHARU; MIYAZAWA KATSUHITO

Art

J-GLOBAL ID：201702290881749545 Reference number：17A1219467

CLINICAL STUDY ON THE EFFICACY AND CONTINUOUS DOCETAXEL BASED CHEMOTHERAPY TREATMENT FOR CASTRATION-RESISTANT PROSTATE CANCER

去勢抵抗性前立腺癌に対するドセタキセル療法の治療効果・投与継続期間に関する検討

Publisher site {{ this.onShowPLink() }} Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=17A1219467&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A1219467&from=J-GLOBAL&jstjournalNo=F0649A") }}

Author (8)： , , , , , , ,
Material：
Volume： 63 Issue： 9 Page： 351-357 Publication year： Sep. 30, 2017
JST Material Number： F0649A ISSN： 0018-1994 CODEN： HIKYAJ Document type： Article
Article type：原著論文 Country of issue： Japan (JPN) Language： JAPANESE (JA)

,...
,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A1219467&from=J-GLOBAL&jstjournalNo=F0649A") }}

Clinical application of antitumor(=antineoplastic)drugs , Drug therapy(=pharmacotherapy)for tumors , Urogenital tumors(=neoplasms)

, , ,

Reference (20)：

千菊敦士,宮崎有,澤崎晴武,ほか:去勢抵抗性前立腺癌に対するドセタキセル療法の継続期間に関わる因子の検討.泌尿紀要 58:273-277,2012
Y Kanda : Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplantation 48 : 452-458, 2012
Tannock IF, de Wit R, Berry WR, et al. : Docetaxel plus prednisone for advanced prostate cancer. N Engl J Med 351: 1502-1512, 2004
Petrylak DP, Tangen CM, Hussain MH, et al. : Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med 351: 1513-1520, 2004
Nelson PS : Molecular states underlyng androgen receptor activation : a frame work for therapeutics targeting androgen signaling in prostate cancer. J Clin Oncol 30 : 644-646, 2012

ｍore...

, , , , ,

Return to Previous Page